Follicle stimulating hormone or clomiphene citrate in intrauterine insemination with ovarian stimulation for unexplained subfertility: a role for treatment selection markers?
- 1 June 2019
- journal article
- research article
- Published by Elsevier in Reproductive BioMedicine Online
- Vol. 38 (6) , 938-942
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Letrozole, Gonadotropin, or Clomiphene for Unexplained InfertilityNew England Journal of Medicine, 2015
- Is IVF—served two different ways—more cost-effective than IUI with controlled ovarian hyperstimulation?Human Reproduction, 2015
- Intrauterine insemination: a UK survey on the adherence to NICE clinical guidelines by fertility clinicsBMJ Open, 2015
- Personalized medicine: Time for one-person trialsNature, 2015
- The influence of the number of follicles on pregnancy rates in intrauterine insemination with ovarian stimulation: a meta-analysisHuman Reproduction Update, 2008
- Ovarian stimulation protocols (anti-oestrogens, gonadotrophins with and without GnRH agonists/antagonists) for intrauterine insemination (IUI) in women with subfertilityCochrane Database of Systematic Reviews, 2007
- A randomized clinical trial of clomiphene citrate versus low dose recombinant FSH for ovarian hyperstimulation in intrauterine insemination cycles for unexplained and male subfertilityHuman Reproduction, 2006
- Pregnancy is predictable: a large-scale prospective external validation of the prediction of spontaneous pregnancy in subfertile couples*Human Reproduction, 2006
- Is controlled ovarian stimulation in intrauterine insemination an acceptable therapy in couples with unexplained non-conception in the perspective of multiple pregnancies?Human Reproduction, 2005
- Inference in Spline‐Based Models for Multiple Time‐to‐Event Data, with Applications to a Breast Cancer Prevention TrialBiometrics, 2003